<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03763461</url>
  </required_header>
  <id_info>
    <org_study_id>112229</org_study_id>
    <nct_id>NCT03763461</nct_id>
  </id_info>
  <brief_title>HFNC During Awake Craniotomy - Impact on Patient Comfort</brief_title>
  <official_title>Comparison of Pre-warmed, Humidified High Flow Nasal Cannula (HFNC) Oxygen Therapy and Traditional Oxygen Therapy on Patient Comfort and Gas Exchange During Awake Craniotomy - A Single Centre, Prospective, Randomized, Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western University, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western University, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Patients undergoing awake brain surgery are exposed to non-humidified, non-warmed&#xD;
      oxygen/air mix flow through a face mask for a prolonged duration. This causes increased&#xD;
      discomfort, inadequate breathing with the risk for hypoxia perioperatively. Humidified high&#xD;
      flow nasal cannula (HFNC) oxygen therapy potentially improves patient comfort, oxygen/air&#xD;
      exchange, improves surgical conditions and prevents atelectasis of the lung, compared to&#xD;
      traditional oxygen administration using a face mask in patients undergoing awake brain&#xD;
      surgery.&#xD;
&#xD;
      Results of this trial will be used to initiate a more extensive, multicenter trial to further&#xD;
      characterize the potential impact of HFNC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Patients undergoing awake brain surgery are exposed to non-humidified, non-warmed&#xD;
      oxygen/air mix flow through a face mask for a prolonged duration. This causes increased&#xD;
      discomfort, inadequate breathing with the risk for hypoxia perioperatively.&#xD;
&#xD;
      Hypothesis: Humidified high flow nasal cannula (HFNC) oxygen therapy improves patient&#xD;
      comfort, oxygen/air exchange, improves surgical conditions and prevents atelectasis of the&#xD;
      lung, compared to traditional oxygen administration using a face mask in patients undergoing&#xD;
      awake brain surgery.&#xD;
&#xD;
      Methods: After obtaining ethics approval and written informed patient consent, 20 patients&#xD;
      undergoing scheduled awake brain surgery will be randomized to either HFNC therapy or&#xD;
      standard face mask. Evaluation of patient satisfaction, pain / dry upper airway along with&#xD;
      drawing of arterial blood gases to measure oxygen/carbon dioxide content of the blood will be&#xD;
      performed during and after the procedure. Lung ultrasound will be performed in the recovery&#xD;
      room to determine the presence of atelectasis.&#xD;
&#xD;
      Expected results and Significance: We expect that HFNC improves patient comfort as well as&#xD;
      breathing / arterial oxygen content in long-duration awake brain surgery. This could result&#xD;
      in higher patient satisfaction, shorter times in PACU, a shorter requirement for oxygen&#xD;
      therapy, decreased risk for hypoxia during surgery and better elimination of carbon dioxide -&#xD;
      which could lead to better surgical conditions due to softer brain tissue and therefore&#xD;
      shorter time for the surgical procedure. Potential positive results of this trial will be&#xD;
      used to initiate a more extensive, multicenter trial to further characterize the potential&#xD;
      impact of HFNC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">February 28, 2021</completion_date>
  <primary_completion_date type="Actual">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient comfort using VAS (1-10)</measure>
    <time_frame>During surgical procedure, an average of 6 hours</time_frame>
    <description>Patient comfort during awake craniotomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gas exchange (blood gas analysis)</measure>
    <time_frame>During surgical procedure (an average of 6 hours) and 15 minutes after PACU admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pulmonary atelectasis using Ultrasound evaluation</measure>
    <time_frame>Up to 15 minutes before PACU discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of oxygen desaturation (number of events with SaO2 &lt; 90%)</measure>
    <time_frame>During surgical procedure, an average of 6 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Pulmonary Atelectasis</condition>
  <condition>Patient Comfort</condition>
  <arm_group>
    <arm_group_label>HFNC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HFNC will be started at flow of 40 L/min and FiO2 of 40%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen Mask</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard non-humidified oxygen therapy via an oxygen mask at 6 l/min will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFNC</intervention_name>
    <description>High flow nasal humidified oxygen HFNC is an air-oxygen blender, which provides high flow (up to 60 L/min) of warmed (36Â°C) and humidified gas through nasal cannula, allowing tighter control of FiO2 from 0.2 to 1.0.</description>
    <arm_group_label>HFNC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen Mask</intervention_name>
    <description>Application of oxygen during conscious sedation</description>
    <arm_group_label>Oxygen Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients undergoing elective awake craniotomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA &gt; 4&#xD;
&#xD;
          -  pregnant females&#xD;
&#xD;
          -  Body Mass Index (BMI) &gt; 40&#xD;
&#xD;
          -  elective postoperative mechanical ventilation/conversion to general anesthesia&#xD;
&#xD;
          -  denial of consent&#xD;
&#xD;
          -  obstructive sleep apnea requiring CPAP&#xD;
&#xD;
          -  severe COPD requiring home oxygen therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>LHSC</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 26, 2018</study_first_submitted>
  <study_first_submitted_qc>December 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2018</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Awake Craniotomy</keyword>
  <keyword>HFNC</keyword>
  <keyword>Oxygen Therapy</keyword>
  <keyword>Atelectasis</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Patient Comfort</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Atelectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

